223 related articles for article (PubMed ID: 38172792)
1. Identification of clinical prognostic factors and analysis of ferroptosis-related gene signatures in the bladder cancer immune microenvironment.
Ma J; Hu J; Zhao L; Wu Z; Li R; Deng W
BMC Urol; 2024 Jan; 24(1):6. PubMed ID: 38172792
[TBL] [Abstract][Full Text] [Related]
2. Development and validation of prognostic index based on purine metabolism genes in patients with bladder cancer.
Wu Z; Feng Z; Wei H; Lin C; Chen K
Front Med (Lausanne); 2023; 10():1193133. PubMed ID: 37780567
[TBL] [Abstract][Full Text] [Related]
3. Ferroptosis-related genes prognostic signature for pancreatic cancer and immune infiltration: potential biomarkers for predicting overall survival.
Wang L; Wu Z; Xu C; Ye H
J Cancer Res Clin Oncol; 2023 Dec; 149(20):18119-18134. PubMed ID: 38007403
[TBL] [Abstract][Full Text] [Related]
4. A novel survival model based on a Ferroptosis-related gene signature for predicting overall survival in bladder cancer.
Liang Y; Ye F; Xu C; Zou L; Hu Y; Hu J; Jiang H
BMC Cancer; 2021 Aug; 21(1):943. PubMed ID: 34418989
[TBL] [Abstract][Full Text] [Related]
5. Generalized machine learning based on multi-omics data to profile the effect of ferroptosis pathway on prognosis and immunotherapy response in patients with bladder cancer.
Liu X; Qiu Z; Zhang X; Su Z; Yi R; Zou D; Xie C; Jin N; Long W; Liu X
Environ Toxicol; 2024 Feb; 39(2):680-694. PubMed ID: 37647346
[TBL] [Abstract][Full Text] [Related]
6. Pyrimidine metabolism regulator-mediated molecular subtypes display tumor microenvironmental hallmarks and assist precision treatment in bladder cancer.
Wu Z; Li X; Gu Z; Xia X; Yang J
Front Oncol; 2023; 13():1102518. PubMed ID: 37664033
[TBL] [Abstract][Full Text] [Related]
7. Identification of a Novel Ferroptosis-Related Gene Prognostic Signature in Bladder Cancer.
Sun J; Yue W; You J; Wei X; Huang Y; Ling Z; Hou J
Front Oncol; 2021; 11():730716. PubMed ID: 34557413
[TBL] [Abstract][Full Text] [Related]
8. Identification of Clinical Prognostic Regulators and Analysis of Ferroptosis-Related Signatures in the Tumor Immune Microenvironment in Lung Squamous Cell Carcinoma.
Wang W; Cui G; Zhao S
Dis Markers; 2023; 2023():9155944. PubMed ID: 36845013
[TBL] [Abstract][Full Text] [Related]
9. A new survival model based on ferroptosis-related genes (FRGS) for prognostic prediction in bladder cancer.
Yang Y; Hu H; Chen L; Zhang H; Yang J
Actas Urol Esp (Engl Ed); 2022 Oct; 46(8):494-503. PubMed ID: 35780051
[TBL] [Abstract][Full Text] [Related]
10. Constructing and validating of m6a-related genes prognostic signature for stomach adenocarcinoma and immune infiltration: Potential biomarkers for predicting the overall survival.
Yang J; Wu Z; Wu X; Chen S; Xia X; Zeng J
Front Oncol; 2022; 12():1050288. PubMed ID: 36620557
[TBL] [Abstract][Full Text] [Related]
11. Multi
Wu M; Li K; Liao Y; Li L; Xiao X; Chen Y; Guo J; Hu F; Qu J; Wang Z; Feng H
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2024 Feb; 49(2):159-174. PubMed ID: 38755712
[TBL] [Abstract][Full Text] [Related]
12. Deciphering the immunological and prognostic features of bladder cancer through platinum-resistance-related genes analysis and identifying potential therapeutic target P4HB.
Xiong S; Li S; Zeng J; Nie J; Liu T; Liu X; Chen L; Fu B; Deng J; Xu S
Front Immunol; 2023; 14():1253586. PubMed ID: 37790935
[TBL] [Abstract][Full Text] [Related]
13. Integrated bioinformatics analysis identifies a Ferroptosis-related gene signature as prognosis model and potential therapeutic target of bladder cancer.
Liu Z; Du D; Zhang S
Toxicol Res (Camb); 2024 Feb; 13(1):tfae010. PubMed ID: 38292893
[TBL] [Abstract][Full Text] [Related]
14. Identification and validation of an individualized prognostic signature of lung squamous cell carcinoma based on ferroptosis-related genes.
Diao X; Guo C; Liu L; Wang G; Li S
Thorac Cancer; 2021 Dec; 12(23):3236-3247. PubMed ID: 34672420
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic Benefits and Prognostic Value of a Model Based on 7 Immune-associated Genes in Bladder Cancer.
Cao M; Cao Y; Xue S; Zhang Q; Zhang H; Xue W
Altern Ther Health Med; 2024 Apr; 30(4):130-138. PubMed ID: 38518167
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of a ferroptosis-related prognostic model for the prediction of progression-free survival and immune microenvironment in patients with papillary thyroid carcinoma.
Huang Y; Xie Z; Li X; Chen W; He Y; Wu S; Li X; Hou B; Sun J; Wang S; He Y; Jiang H; Lun Y; Zhang J
Int Immunopharmacol; 2021 Dec; 101(Pt A):108156. PubMed ID: 34624650
[TBL] [Abstract][Full Text] [Related]
17. Prognosis analysis and validation of lipid metabolism-associated lncRNAs and tumor immune microenvironment in bladder cancer.
Tan Z; Fu S; Zuo J; Wang J; Wang H
Aging (Albany NY); 2023 Aug; 15(16):8384-8407. PubMed ID: 37632832
[TBL] [Abstract][Full Text] [Related]
18. An effective N6-methyladenosine-related long non-coding RNA prognostic signature for predicting the prognosis of patients with bladder cancer.
Ma T; Wang X; Meng L; Liu X; Wang J; Zhang W; Tian Z; Zhang Y
BMC Cancer; 2021 Nov; 21(1):1256. PubMed ID: 34802433
[TBL] [Abstract][Full Text] [Related]
19. A Novel Prognostic Signature Based on Ferroptosis-Related Genes Predicts the Prognosis of Patients With Advanced Bladder Urothelial Carcinoma.
Li X; Huang J; Chen J; Zhan Y; Zhang R; Lu E; Li C; Zhang Y; Wang Y; Li Y; Zheng J; Geng W
Front Oncol; 2021; 11():726486. PubMed ID: 34966666
[TBL] [Abstract][Full Text] [Related]
20. A Novel Prognostic Model Based on Ferroptosis-Related Gene Signature for Bladder Cancer.
Yang L; Li C; Qin Y; Zhang G; Zhao B; Wang Z; Huang Y; Yang Y
Front Oncol; 2021; 11():686044. PubMed ID: 34422642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]